Farag Kameel D. (CIK 2093620) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-25). Recent activity: Buy AKTX (1,248 shares), Buy AKTX (1,395 shares), Buy AKTX (1,570 shares), Buy AKTX (2,539 shares), Buy AKTX (3,725 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-25 | Akari Therapeutics Plc (AKTX) | Interim CFO | Buy | 1,248 | $12,505 |
| 2026-06-25 | Akari Therapeutics Plc (AKTX) | Interim CFO | Buy | 1,395 | $13,001 |
| 2026-06-25 | Akari Therapeutics Plc (AKTX) | Interim CFO | Buy | 1,570 | $13,000 |
| 2026-06-25 | Akari Therapeutics Plc (AKTX) | Interim CFO | Buy | 2,539 | $13,000 |
| 2026-06-25 | Akari Therapeutics Plc (AKTX) | Interim CFO | Buy | 3,725 | $13,000 |
| 2026-06-25 | Akari Therapeutics Plc (AKTX) | Interim CFO | Buy | 7,353 | $27,500 |
| 2026-06-25 | Akari Therapeutics Plc (AKTX) | Interim CFO | Buy | 1,000 | $13,000 |
| 2025-11-04 | Akari Therapeutics Plc (AKTX) | Interim CFO | Buy | 32,000 | $24,000 |
| 2025-11-04 | Akari Therapeutics Plc (AKTX) | Interim CFO | Buy | 26,619 | $19,964 |
| 2025-10-24 | Akari Therapeutics Plc (AKTX) | Interim CFO | Buy | 6,277 | $4,645 |
Source: SEC Form 4 filings · as of 2026-06-25